Global Oncology Nutrition market trends 2024, Forecast To 2033
7 Feb, 2024
The oncology nutrition market has witnessed rapid growth, increasing from $1.74 billion in 2023 to $1.93 billion in 2024, reflecting a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period is attributed to an aging population, improved healthcare infrastructure, research and development investments, patient-centric care, and a rise in healthcare spending. Anticipating strong growth in the next few years, the market size is expected to reach $2.81 billion in 2028, supported by an expected CAGR of 9.9%. This growth in the forecast period is linked to increasing cancer incidence, a rise in demand for nutritional food, an increase in clinical trials globally, and rising disposable income. Major trends in the forecast period include personalized nutrition, immuno-nutrition, genomic nutrition, integrative medicine, and value-based care.
Global Oncology Nutrition Market Key Driver
The escalating prevalence of cancer is a significant driver for the oncology nutrition market. The increase in cancer cases, as reported by the American Cancer Society, indicates a 3.16% growth from 2021 to 2023, reaching 1,958,310 cases. This rise underscores the need for adequate nutrition among cancer patients. The growing incidence of cancer is poised to contribute substantially to the expansion of the oncology nutrition market. (2023: 1,958,310, 2024: - , 2028: -)
Get A Free Sample Of The Global Oncology Nutrition Market ReportGlobal Oncology Nutrition Market Segments
The global oncology nutrition market covered in this report is segmented –
1) By Cancer Type: Blood Cancer, Breast Cancer, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types
2) By Nutrition: Enteral Nutrition, Parenteral Nutrition
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End Users
By Geography: The regions covered in the Oncology Nutrition market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
North Americawas the largest region in the oncology nutrition market in 2023. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Major Oncology Nutrition Industry Players
B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S.A., Hormel Foods Corporation, Meiji Holdings Co. Ltd., Pfizer Inc., Baxter International Inc., Mead Johnson Nutrition Company LLC, Fresenius Kabi AG, Auris Health Inc., Aceto Corporation, Hansen Medical Inc., FMC Corporation, Mead Johnson & Company LLC, Global Health Products Inc., Nutricia, Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Abbott Nutrition, Fresenius Kabi USA LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Pinnacle Foods Inc., Primus Pharmaceuticals Inc., Solace Nutrition, The Simply Good Foods Company, Unimed Pharma LLC, Vitaflo USA LLC
Get The Full Global Oncology Nutrition Market Report
Oncology Nutrition Market Overview
Oncology nutrition refers to eating a healthy and balanced diet prescribed for a cancer patient. Eating the right kinds of food before, during, and after treatment can help patients feel better and stay stronger. Oncology nutrition is used to improve clinical outcomes in certain cancer types.
Oncology Nutrition Global Market Report 2023 provides data on the global oncology nutrition market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The oncology nutrition market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.